Leveraging recent advances in plasma biomarkers to optimize early proof of concept trials in Alzheimer's disease
Authors
- Suzanne Hendrix (ORCID: https://orcid.org/0000-0002-2374-7727)
- Trevor Duke (ORCID: https://orcid.org/0000-0003-4637-1416)
- Johanne Kaplan
- Samuel Dickson (ORCID: https://orcid.org/0000-0001-7503-8757)
- Craig Mallinckrodt
- G Duncan (ORCID: https://orcid.org/0009-0008-6978-3556)
- Larry D. Altstiel
- Samuel Johnson
- Caleb W. Dayley
Institutions
- Cambridge Scientific (United States) (US)
- Statistical Research (United States) (US)
Publication Details
- Journal
- Alzheimer s & Dementia Translational Research & Clinical Interventions
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1002/trc2.70183
- Citations
- 1
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 1.47